<?xml version="1.0" encoding="UTF-8"?>
<p>We provided a detailed analysis of HCV epidemiology in populations with LRDs in MENA. To our knowledge, this is the first such analysis for any region. HCV infection appeared to play a major, if not dominant, role in different liver disease forms in Egypt and Pakistan but much less so for the other MENA countries (Table 
 <xref rid="hep41491-tbl-0002" ref-type="table">2</xref>). The majority of cases of HCC, cirrhosis, and other liver disease forms were found to be exposed to HCV infection in these two countries, suggesting that this infection is the main driver of this disease burden as opposed to other causes (such as hepatitis B virus infection). The role of HCV in liver diseases was found to be 8‐fold higher in Egypt and 5‐fold higher in Pakistan compared to the other countries (Table 
 <xref rid="hep41491-tbl-0003" ref-type="table">3</xref>). These findings should not be surprising given the high HCV prevalence and unique nature of epidemics in these two countries
 <xref rid="hep41491-bib-0008" ref-type="ref">8</xref>, 
 <xref rid="hep41491-bib-0009" ref-type="ref">9</xref>, 
 <xref rid="hep41491-bib-0010" ref-type="ref">10</xref>, 
 <xref rid="hep41491-bib-0011" ref-type="ref">11</xref>, 
 <xref rid="hep41491-bib-0027" ref-type="ref">27</xref>, 
 <xref rid="hep41491-bib-0028" ref-type="ref">28</xref>, 
 <xref rid="hep41491-bib-0029" ref-type="ref">29</xref>, 
 <xref rid="hep41491-bib-0043" ref-type="ref">43</xref> relative to the rest of MENA.
 <xref rid="hep41491-bib-0016" ref-type="ref">16</xref>, 
 <xref rid="hep41491-bib-0017" ref-type="ref">17</xref>, 
 <xref rid="hep41491-bib-0018" ref-type="ref">18</xref>, 
 <xref rid="hep41491-bib-0019" ref-type="ref">19</xref>, 
 <xref rid="hep41491-bib-0020" ref-type="ref">20</xref>, 
 <xref rid="hep41491-bib-0021" ref-type="ref">21</xref>, 
 <xref rid="hep41491-bib-0043" ref-type="ref">43</xref>, 
 <xref rid="hep41491-bib-0044" ref-type="ref">44</xref>
</p>
